Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Correlation Between Visfatin, Insulin Resistance (Homeostasis Model Assesment of Insulin Resistance), Inflammation (High Sensitivity C-Reactive Protein) and HDL Cholesterol Concentration in Individuals with Visceral Obesity

The Indonesian Biomedical Journal · Vol. 2 No. 1 (2010) · pp. 61–61

DOI
10.18585/inabj.v2i1.111
ISSN
2085-3297, 2355-9179
Published
2010-04-01
Publisher
Secretariat of The Indonesian Biomedical Journal
Language
en
License
creativecommons.org/licenses/by-nc/4.0/

Abstract

BACKGROUND: Visfatin is a novel adipokine secreted from visceral adipose tissue and has insulinomimetic properties. Visceral obesity is a risk factor for metabolic syndrome. Insulin resistance and inflammation are linked to visceral obesity and metabolic syndrome. Dysregulation of visfatin as an adipokine could play an important role in metabolic syndrome through insulin resistance and inflammation, or lower HDL cholesterol concentration. However, this need more evidence.METHOD: This was a crossectional study in 40 Indonesian obese men and 40 Indonesian obese women. Age: 30-60 years in men and 50-60 years for women, from February to March 2008 in Jakarta.RESULTS: No correlation between visfatin and hs-CRP as a marker of inflammation (r=0.190, p=0,101), or HOMA-IR as a marker of insulin resistance (r=-0.020, p=0.246). Suprisingly visfatin concentration is correlated with HDL Cholesterol (r=0.416, p=0.000).CONCLUSIONS: Visfatin plays an important role in metabolic syndrome through lipid metabolism. Positive correlation between visfatin and HDL cholesterol, was assumed that visfatin had a protective effect. Visfatin also known as as nicotinamide phosphoribosyltransferase (NAMPT) links Nicotinamide Adenine Dinucleotide (NAD) metabolism and raising of HDL Cholesterol. But the exact mechanisms need to be further studied.KEYWORDS: visceral obesity, metabolic syndrome, NAMPT, visfatin, HDL

Keywords

Collaboration network of the authors

40 authors · 120 co-authorship links · 53 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Hasanuddin University
  • Padjadjaran University
  • PT Prodia StemCell Indonesia (Indonesia)
  • University of Indonesia
  • SEAMEO Regional Center for Food and Nutrition
  • Udayana University
  • Universitas Trisakti
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Anna MeilianaPadjadjaran University87
Nurrani Mustika DewiPadjadjaran University45
Suryani As’ádHasanuddin University14
Yani LinaHasanuddin University6
Gatot Susilo LawrenceHasanuddin University6
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)5
Ilhamjaya PatellongiHasanuddin University4
Anwar SantosoUdayana University4
Syakib BakriHasanuddin University4
Teguh RanakusumaUniversity of Indonesia3
Irawan YusufHasanuddin University3
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)3
Trilis YuliantiHasanuddin University3
Indriyanti Rafi SukmawatiHasanuddin University3
Yenny SurjawanHasanuddin University2
Irma Ruslina DefiPadjadjaran University2
Mansyur AriefHasanuddin University2
Andri HidayatHasanuddin University2
Melisa Intan BarlianaPadjadjaran University2
Keri Lestari DandanPadjadjaran University2
Ferry SandraUniversitas Trisakti2
Ahmad FariedPadjadjaran University2
Keri LestariPadjadjaran University2
Marsetio DonosepoetroUniversitas Airlangga2
Burhanuddin BaharHasanuddin University2
Lucia HerminawatiHasanuddin University2
Antonia Anna LukitoHasanuddin University2
Mansyur ArifHasanuddin University2
Ray Wagiu BasrowiUniversity of Indonesia1
Luciana Budiati SutantoKrida Wacana Christian University1
Candra NinghayuHasanuddin University1
Anna MeilanaPadjadjaran University1
Aziiz Mardanarian RosdiantoPadjadjaran University1
Adziqa Ammara QiantoriPadjadjaran University1
Bachtiar MurtalaHasanuddin University1
Terawan Agus PutrantoGatot Soebroto Army Hospital1
Hera Yuliana IntantriAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Correlation Between Visfatin, Insulin Resistance (Homeostasis Model Assesment of Insulin Resistance), Inflammation (High Sensitivity C-Reactive Protein) and HDL Cholesterol Concentration in Individuals with Visceral Obesity</dc:title><dc:creator>Rini Budiyati</dc:creator><dc:creator>Widjaja Lukito</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:subject>visfatin</dc:subject><dc:subject>visceral obesity</dc:subject><dc:subject>metabolic syndrome</dc:subject><dc:subject>insulin resistance</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>HDL cholesterol</dc:subject><dc:subject>adipokines</dc:subject><dc:subject>NAD+ metabolism</dc:subject><dc:subject>high-sensitivity C-reactive protein</dc:subject><dc:subject>HOMA-IR</dc:subject><dc:description xml:lang="en">BACKGROUND: Visfatin is a novel adipokine secreted from visceral adipose tissue and has insulinomimetic properties. Visceral obesity is a risk factor for metabolic syndrome. Insulin resistance and inflammation are linked to visceral obesity and metabolic syndrome. Dysregulation of visfatin as an adipokine could play an important role in metabolic syndrome through insulin resistance and inflammation, or lower HDL cholesterol concentration. However, this need more evidence.METHOD: This was a crossectional study in 40 Indonesian obese men and 40 Indonesian obese women. Age: 30-60 years in men and 50-60 years for women, from February to March 2008 in Jakarta.RESULTS: No correlation between visfatin and hs-CRP as a marker of inflammation (r=0.190, p=0,101), or HOMA-IR as a marker of insulin resistance (r=-0.020, p=0.246). Suprisingly visfatin concentration is correlated with HDL Cholesterol (r=0.416, p=0.000).CONCLUSIONS: Visfatin plays an important role in metabolic syndrome through lipid metabolism. Positive correlation between visfatin and HDL cholesterol, was assumed that visfatin had a protective effect. Visfatin also known as as nicotinamide phosphoribosyltransferase (NAMPT) links Nicotinamide Adenine Dinucleotide (NAD) metabolism and raising of HDL Cholesterol. But the exact mechanisms need to be further studied.KEYWORDS: visceral obesity, metabolic syndrome, NAMPT, visfatin, HDL</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2010-04-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v2i1.111</dc:identifier><dc:identifier>10.18585/inabj.v2i1.111</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 2 No 1 (2010); 61-61</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/111/138</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>